 HOLON, Israel, Oct. 1, 2021 PRNewswire -- Compugen Ltd. NASDAQ: CGEN, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that new clinical and preclinical data will be presented at the 36th Annual Meeting of the Society for Immunotherapy of Cancer, which will be held on November 10-14, 2021. 